Dr. Christopher John Dimaio, MD

Dr. Dimaio practices at Long Island Center for Digestive Health in Uniondale, New York.

Dr. Dimaio's NPI, 1295930840, was assigned on June 15, 2007. Dr. Dimaio graduated from Jacobs School of Medicine and Biomedical Sciences in 2000. Dr. Dimaio holds New York license 232631.

Dr. Dimaio's primary practice is Long Island Center for Digestive Health, at 106 Charles Lindbergh Boulevard, Uniondale, NY 11553. The practice phone is (516) 794-1868.

Dr. Dimaio's primary practice is Long Island Center for Digestive Health in Uniondale, New York. Dr. Dimaio is also affiliated with North Shore University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Dimaio to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dimaio practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Dimaio's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Dimaio is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Dimaio's licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists acid reflux, colonoscopy, esophagus, stomach, or upper small intestine surgery, gastroenteritis, gastrointestinal bleeding, intestinal diverticulosis, irritable bowel syndrome (IBS) and pancreas or bile duct endoscopy (ERCP) among the conditions Dr. Dimaio treats.

CMS data shows 815 Medicare services from Dr. Dimaio across 17 procedure codes in 2024, for 392 Medicare patients. Medicare paid $95,835 for them.

CMS counts 392 Medicare patients who saw Dr. Dimaio in 2024. The largest group is 75 to 84, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dimaio's median patient age at 71, with 51% women.

In 2024, Dr. Dimaio wrote 292 Medicare Part D claims for 100 patients. 81% of them were for generic drugs. CMS names the drug for 225 of them, across 6 drugs with 11 or more claims each, at $98,413 in total drug cost. In 2023, CMS named 181 claims across 7 drugs.

Dr. Dimaio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dimaio as offering telehealth. CMS counts 232 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Dimaio, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 88 papers to Dr. Dimaio, published from 2009 to 2024. 2015 was the busiest year, with 11. The most frequent topics are Endosonography, Pancreatic Neoplasms and Stents. Dr. Dimaio has published most often in Gastrointest Endosc. Dr. Dimaio's most frequent co-authors are Satish Nagula, MD, Nikhil A. Kumta, MD, MS and Dennis J. Yang, MD.

CMS Open Payments shows 172 general payments to Dr. Dimaio from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $40,676. It also lists 1 research payment totaling $2,664 in 2016.

Dmand AI lists 1 award for Dr. Dimaio, most recently CMS Stage 1 EHR in 2013.

Dr. Dimaio graduated from Jacobs School of Medicine and Biomedical Sciences in 2000.

Dr. Dimaio is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.